Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo

International Journal of Ophthalmology

Volumn 5, Issue 4, 2012, Pages 440-447

  Xin, Guo Hong ^a   Zhao, Xin Han ^a   Liu, Dong ^b   Gong, Qiang ^c   Hou, Lei ^a   Li, Jing Yun ^c   Pan, Bo Rong ^d   Li, Xu ^e   Cheng, Ya Jie ^a  

^a First Affiliated Hospital   (China)

^b Central Hospital of Shanghai Jiading District   (China)

^c Third Hospital of Baoding   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e Shaanxi Provincial Tumor Hospital   (China)

Author keywords

Angiogenesis; Antisense oligonucleotides; Gene therapy; Generation 4 poly amidoamine; Retinoblastoma; Vascular endothelial growth factor

Indexed keywords

EID: 84894524876     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2012.04.07     Document Type: Article

References (34)

1. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25(38):5341-5349.
2. Long H, Zhou B, Jiang FG Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. Int J Ophthalmol. 2011;4(5):489-491.
3. Shan GY, Zhang JH, Lü YG, Yun J. Bioinformatics-led design of single-chain antibody molecules targeting DN A sequences for retinoblastoma. Int J Ophthalmol. 2011;4(1):8-13.
4. Bautch VL, Ambler CA Assembly and patterning of vertebrate blood vessels. Trends Cardiovasc Med. 2004;14(4):138-143.
5. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581-611.
6. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9(6):685-693.
7. Hicklin DJ, Ellis LM Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23(5):1011-1027.
8. Naumov GN, Folkman J, Straume O., Akslen LA Tumor-vascular interactions and tumor dormancy. Apmis. 2008;116(7-8):569-585.
9. Almog N, Ma L, Raychowdhury R., Schwager C, Erber R, Short S., Hlatky L, Vajkoczy P, Huber PE, Folkman J, Abdollahi A. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res. 2009;69(3):836-844.
10. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149-153.
11. Nussenbaum F, Herman IM Tumor angiogenesis: insights and innovations. J Oncol. 2010;2010:132641.
12. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-676.
13. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353-364.
14. Sledge GW., Jr Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin Oncol. 2002;29(3):104-110.
15. Lyons JM, 3rd, Schwimer JE, Anthony CT, Thomson JL, Cundiff JD, Casey DT, Maccini C, Kucera P, Wang YZ, Boudreaux JP, Woltering EA. The role of VEGF pathways in human physiologic and pathologic angiogenesis. J Surg Res. 2010;159(1):517-527.
16. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2009;29(6):789-791.
17. Gimbrone MA, Jr, Leapman SB, Cotran RS, Folkman J. Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. J Natl Cancer Inst. 1973;50(1):219-228.
18. Rafii S, Lyden D, Benezra R., Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer. 2002;2(11):826-835.
19. Kaplan RN, Riba RD, Zacharoulis S, Bramley A H, Vincent L, Costa C., MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820-827.
20. Wacheck V, Zangemeister-Wittke U. Antisense molecules for targeted cancer therapy. Crit Rev Oncol Hematol. 2006;59(1):65-73.
21. Tai W, Qin B, Cheng K. Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF. Mol Pharm. 2010;7(2):543-556.
22. Crawford Y, Ferrara N. VEGF inhibition: insights from preclinical and clinical studies. Cell Tissue Res. 2009;335(1):261-269.
23. Reck M, Crino L. Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer. Lung Cancer. 2009;63(1):1-9.
24. Kukowska-Latallo J.F., Bielinska AU, Johnson J, Spindler R., Tomalia DA, Baker JR, Jr Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 1996;93(10):4897-4902.
25. Maiti PK, Cagin T, Wang G.F., Goddard III WA. Structure of PAMAM dendrimers: Generations 1 through 11. Macromolecules. 2004;37:6236-6254.
26. Bielinska A, Kukowska-Latallo JF, Johnson J., Tomalia DA, Baker JR, Jr Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996;24(11):2176-2182.
27. Kubasiak LA, Tomalia DA Chapter 9. Boca Raton: CRC Press; 2004. Cationic dendrimers as gene transfection vectors: dendri-poly(amidoamines) and dendri-poly (propylenimines); pp. 133-157.
28. Braun CS, Vetro JA, Tomalia D.A., Koe GS, Koe JG, Middaugh CR Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci. 2005;94(2):423-436.
29. Abdelhady HG, Allen S, Davies M.C., Roberts CJ, Tendler SJ, Williams PM Direct real-time molecular scale visualisation of the degradation of condensed DN A complexes exposed to DNase I. Nucleic Acids Res. 2003;31(14):4001-4005.
30. Shakhbazau A, Isayenka I, Kartel N., Goncharova N, Seviaryn I, Kosmacheva S., Potapnev M, Shcharbin D, Bryszewska M. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. Int J Pharm. 2010;383(1-2):228-235.
31. Morgan DM, Larvin VL, Pearson JD Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. J Cell Sci. 1989;94(Pt 3):553-559.
32. Rejman J, Bragonzi A, Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther. 2005;12(3):468-474.
33. Gu SZ, Zhao XH, Zhang L.X., Li L., Wang ZY, Meng M, An GL Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro. J Zhejiang Univ Sci B. 2009;10(3):159-167.
34. Jia RB, Zhang P, Zhou Y.X., Song X., Liu HY, Wang LZ, Luo M, Lu J., Ge SF, Fan XQ. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res. 2007;39(2):108-115.